Profile data is unavailable for this security.
About the company
Fuji Pharma Co., Ltd. is a Japan-based company mainly engaged in the manufacture and sale of medical products. The Company is engaged in the manufacture and sale of hormone medicines for obstetrics and gynecology department, as well as injectable drugs for radiological department such as radiopaque dye for urinary tracts and blood vessels through its branches. In addition, the Company purchases its main pharmaceutical ingredients from its main parent company.
- Revenue in JPY (TTM)44.56bn
- Net income in JPY6.36bn
- Incorporated1965
- Employees1.62k
- LocationFuji Pharma Co Ltd5-7, Samban-cho6F, Seito Kaikan,CHIYODA-KU 102-0075JapanJPN
- Phone+81 335563344
- Fax+81 335564455
- Websitehttps://www.fujipharma.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stella Pharma Corp | 269.49m | -759.81m | 18.11bn | 44.00 | -- | 6.43 | -- | 67.19 | -24.30 | -24.30 | 8.62 | 82.71 | 0.0594 | 0.0517 | 3.98 | 6,124,796.00 | -16.73 | -22.50 | -17.64 | -24.83 | 80.37 | -- | -281.94 | -488.65 | 15.60 | -943.38 | 0.2481 | -- | 17.65 | -- | 1.94 | -- | -5.87 | -- |
| TAIKO PHARMACEUTICAL CO LTD | 6.49bn | -2.33bn | 20.51bn | 208.00 | -- | 2.52 | -- | 3.16 | -46.91 | -46.91 | 130.40 | 160.86 | 0.4474 | 1.91 | 3.71 | 31,211,540.00 | -16.07 | -- | -19.68 | -- | 49.37 | -- | -35.92 | -- | 2.95 | -- | 0.2437 | -- | 21.43 | -- | 26.23 | -- | -- | -- |
| Astena Holdings Co Ltd | 53.22bn | 2.10bn | 21.15bn | 1.40k | 9.75 | 0.7188 | 4.86 | 0.3974 | 52.92 | 52.92 | 1,343.58 | 717.87 | 0.8105 | 3.42 | 2.73 | 37,904,980.00 | 3.18 | 2.49 | 5.77 | 4.44 | 33.18 | 25.33 | 3.93 | 2.32 | 0.889 | -- | 0.3439 | 44.92 | 4.73 | -2.85 | 100.61 | -3.85 | 38.54 | 11.38 |
| Fuso Pharmaceutical Industries Ltd | 56.52bn | 1.53bn | 21.15bn | 1.31k | 12.50 | 0.5132 | 5.61 | 0.3742 | 179.11 | 179.11 | 6,607.60 | 4,361.00 | 0.7454 | 3.08 | 2.35 | 43,245,600.00 | 2.02 | 1.91 | 3.50 | 3.09 | 25.67 | 26.92 | 2.71 | 2.69 | 0.9393 | 36.59 | 0.2767 | 41.10 | 8.61 | 3.76 | -14.21 | 9.02 | 9.13 | -2.64 |
| CanBas Co Ltd (Parent) | 0.00 | -1.21bn | 23.84bn | 12.00 | -- | 9.81 | -- | -- | -67.63 | -67.63 | 0.00 | 129.88 | 0.00 | -- | -- | -- | -53.54 | -62.25 | -56.62 | -70.91 | -- | -- | -- | -- | 25.09 | -- | -- | -- | -- | -- | 2.77 | -- | -- | -- |
| CellSeed Inc | 199.47m | -957.04m | 27.21bn | 35.00 | -- | 12.40 | -- | 136.39 | -30.72 | -30.72 | 6.40 | 63.29 | 0.0892 | 1.65 | 7.91 | 5,699,172.00 | -42.79 | -49.69 | -46.02 | -54.55 | 55.38 | 63.66 | -479.79 | -428.62 | 16.42 | -5,460.76 | 0.0651 | -- | 50.39 | -28.62 | -11.43 | -- | 80.73 | -- |
| StemRIM Inc | 0.00 | -2.02bn | 27.87bn | 44.00 | -- | 3.13 | -- | -- | -32.98 | -32.98 | 0.00 | 144.57 | 0.00 | -- | -- | -- | -20.44 | -8.34 | -20.74 | -8.49 | -- | -- | -- | -68.74 | 131.03 | -11,344.72 | -- | -- | -100.00 | -- | -1,301.17 | -- | -4.35 | -- |
| Fuji Pharma Co Ltd | 44.56bn | 6.36bn | 31.26bn | 1.62k | 4.82 | 0.683 | 3.17 | 0.7016 | 261.79 | 261.79 | 1,833.31 | 1,849.15 | 0.5156 | 1.40 | 3.15 | 27,490,440.00 | 7.36 | 4.10 | 11.63 | 5.58 | 39.28 | 42.41 | 14.28 | 7.55 | 0.6276 | -- | 0.3912 | 31.17 | 15.42 | 1.52 | 27.41 | 0.3709 | 19.04 | 5.73 |
| Daito Pharmaceutical Co Ltd | 46.90bn | 3.30bn | 34.87bn | 1.07k | 10.81 | 0.6673 | 5.10 | 0.7436 | 210.18 | 210.18 | 2,988.66 | 3,404.72 | 0.6326 | 1.89 | 2.96 | 43,827,100.00 | 4.29 | 6.27 | 5.58 | 8.24 | 20.98 | 22.65 | 6.78 | 8.47 | 1.11 | -- | 0.143 | 19.59 | 3.98 | 2.66 | -8.47 | -1.27 | 11.37 | 11.67 |
Data as of Sep 20 2024. Currency figures normalised to Fuji Pharma Co Ltd's reporting currency: Japanese Yen JPY
9.83%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 05 Aug 2024 | 548.00k | 2.21% |
| The Vanguard Group, Inc.as of 04 Sep 2024 | 526.12k | 2.13% |
| Dimensional Fund Advisors LPas of 05 Sep 2024 | 340.29k | 1.38% |
| Nikko Asset Management Co., Ltd.as of 06 Sep 2024 | 270.40k | 1.09% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 261.30k | 1.06% |
| Daiwa Asset Management Co. Ltd.as of 30 Aug 2024 | 205.20k | 0.83% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 05 Sep 2024 | 89.50k | 0.36% |
| Mellon Investments Corp.as of 05 Sep 2024 | 69.20k | 0.28% |
| Dimensional Fund Advisors Ltd.as of 05 Sep 2024 | 67.99k | 0.28% |
| Samarang LLPas of 30 Jun 2022 | 55.70k | 0.23% |
More ▼
Data from 30 Jun 2022 - 30 Jun 2024Source: FactSet Research Systems Inc.
